In contrast, there is no specific enrichment with a FOXM1 antibody at the promoters of H19, myoglobin and CCND1 3 which are genes non-expressed or imprinted in glioma cells (they serve as negative controls). The gene discussed is H19; the disease is central nervous system cancer.